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Volume 51, Number 11S Abstracts 59Santegrade subintimal angioplasty. The site of initial techni-
cal failure was the popliteal artery in 12 patients and the
proximal trifurcation vessels in two. Technical success was
achieved in all 14 patients. There were no complications
from the distal arterial access in any of the patients, docu-
mented in all cases by noninvasive lab assessment.
Conclusions: In a selected population of patients with
femoropopliteal arterial occlusion, distal arterial access in the
dorsalis pedis or posterior tibial arterymay allow technical success
to be achieved. Using the distal artery for retrograde access may
be an important adjunct for treatment of complicated femoro-
popliteal occlusions.
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Objectives: There has been increased use of percuta-
neous transluminal angioplasty /- stent (PTA) for clau-
dication. We set forth to investigate long-term outcomes of
PTA compared to bypass (BPG) as primary intervention.
Methods:Aretrospective cohort single institution review
of claudication interventions by BPG from 2001-2009 and
PTA from 2005-2009 looked at patient demographics, med-
ications, TASC classification, runoff, complications, and co-
morbidities. Patency (70% stenosis), symptom recurrence,
mortality, and reinterventions were used to assess durability.
Results:Wereviewed113BPGand104PTAof femoral-
popliteal lesionswithout prior interventions.Mean agewas 63
vs 69 (p  0.01). Length of stay (LOS) was 3.9 vs 1.2 days
(p  0.01). BPG had less TASC A (17 vs 40%, p  0.01),
more TASCC (36 vs 11%, p 0.01) and TASCD (13 vs 3%,
p  0.01) lesions. There was no difference in 30-day periop-
erative (1.8 vs 0%, NS) or long-term mortality (91 vs 92% - 3
years, NS). Wound infection was higher with BPG (15.9 vs
0%, p  0.01). BPG had improved primary patency (73% vs
42% - 3 years, p 0.01), freedom from symptom recurrence
(70 and 36% at 3 years p  0.01), and symptoms at last
follow-up (9% vs 27% p  0.01). There was no difference in
freedom from reinterventions (77 vs 66% at 3 years, NS).
None proceeded to amputation. Multivariate analysis shows
that PTA and TASCDwere predictive of patency failure (HR
2.5, 95% CI 1.4-4.4, HR 3.7, 95% CI 3.5-9) and recurrence
of symptoms (HR3.0, 95%CI 1.8-5,HR3.1, 95%CI 1.4-7).
Statin use postoperatively was predictive of patency (HR 0.6
95% CI 0.35-0.97) and freedom from symptoms (HR 0.6
95% CI 0.36-0.93).
Conclusions: BPG for claudication showed increased
patency and symptom relief despite treatment of more
extensive disease, but was associated with increased LOSand wound infection. Statins improved patency and free-
dom from symptom recurrence overall.
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Objectives: To retrospectively analyse long-term out-
come of common femoral endarterectomy (CFE) at a sin-
gle tertiary referral centre.
Methods: A review of outcome following CFE was
performed. Freedom from reintervention in ipsilateral limb
and limb salvage were determined using Kaplan-Meier
life-table analysis. Factors associated with adverse outcome
were assessed by Cox Regression analysis.
Results: CFE was performed on 87 limbs in 81 patients
(mean age 71 11; male 69%). 45 (52%) were performed for
incapacitating claudication and 42 (48%) for critical limb
ischaemia. 25 (29%)were performedwith adjunctive inflowor
outflow procedures. CFE was combined with profundaplasty
in 74 (85%) and patch angioplasty in 85 (98%) patients.
Technical success ratewas 100%with 30-day clinical success of
96%. Mean postoperative increase in ABPI was 0.32 0.19.
There were 4 (5%) major and 8 (9%) minor complications
with 1 (1%) perioperative death. Mean follow-up was 23
months (range 1-144 months). Primary patency and assisted
patency at 3 years were 93% and 99% respectively. There was
no difference in patency in CFE performed alone or as com-
bined procedure. No patient-related or intraoperative factors
were associatedwith increased risk of recurrence of symptoms.
Freedom from reintervention in ipsilateral limb was 79% at 2
years and 62% at 6 years. Freedom from amputation at 6 years
was 87% and significantly increased amputation risk was iden-
tified in patients on haemodialysis for chronic renal failure (by
long-rank test, p 0.001).
Conclusions:CommonFemoral Endarterectomy is safe,
durable and effective and can be performed under local anaes-
thesia which is helpful for limb salvage in unfit patients. It is
gold standard for occlusive CFA disease against which emerg-
ing endovascular therapies should be compared.
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